Trademarkia Logo

Canada

C$
NEWLUX
ADVERTISED

on 24 Jan 2025

Last Applicant/ Owned by

Medytox Inc.

78, Gangni 1-gil, Ochang-eup,Cheongwon-gu, Cheongju-siChungcheongbuk-do

KR

Serial Number

2196406 filed on 16th May 2022

Registration Number

TMA1286186 registered on 24th Jan 2025

Registration expiry Date

16th May 2032

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

NEWLUX

Trademark usage description

pharmaceutical agents for treating sensory organ disorders; muscle relaxants; preparations for the treatment of muscle fatigue; pharmaceutical agents Read More

Classification Information


Class [005]
Pharmaceutical agents for treating sensory organ disorders; muscle relaxants; preparations for the treatment of muscle fatigue; pharmaceutical agents for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceuticals containing botulinum toxin for medical use for use in treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, excessive sweating, excessive sebum secretion, neuropathy pain and pelvic pain; bacteria poisons; pharmacological preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; chemico-pharmaceutical preparations for skin care, skin wounds, prevention of migraines; medicated lotions for skin, sunburn, face, body; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, excessive sweating, excessive sebum secretion, neuropathy pain and pelvic pain; injectable dermal fillers; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pain relief medication.


Classification kind code

11

Mark Details


Serial Number

2196406

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 1st Feb 2024
Agent Changed
Submitted for opposition 22
on 16th Oct 2023
Search Recorded
Submitted for opposition 20
on 16th Oct 2023
Examiner's First Report
Submitted for opposition 223
on 16th Oct 2023
Total Provisional Refusal
Submitted for opposition 256
on 8th May 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 7th Jul 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 6th Jul 2022
Formalized
Submitted for opposition 1
on 6th Jul 2022
Created
Submitted for opposition 228
on 16th May 2022
International Registration
Submitted for opposition 30
on 16th May 2022
Filed